Table 1.

Common adverse events in the TROPIC trial (restricted to those with ≥5% incidence at grade ≥3 in the cabazitaxel arm)²

Adverse events experienced by patients*	Cabazitaxel (n=371)		Mitoxantrone (n=371)
	Any grade, %	Grade ≥3, %	Any grade, %	Grade ≥3, %
Febrile neutropenia	-	8	-	1
Diarrhea	47	6	11	<1
Fatigue	37	5	27	3
Asthenia	20	5	12	2

^*Excludes hematological events detected by laboratory tests, but not described clinically.